160 OÊı·ÏÌÔÏÔÁ›·, 14, 2 (2002)national Edition, Vol 7, No 6; 18-19, 1995.10. ¢ÂÚÂÎÏ‹˜ ¢, §¿Î , ΔÂÚ˙›‰o˘ Ã, ºÈÏ›‰Ë˜ ∫. ∏ ¯ÂÈÚo˘Ú-ÁÈ΋ ·ÓÙÈÌÂÙÒappleÈÛË Ùo˘ ÛÈÏÈÎoÓÔÁÂÓo‡˜ ηٷÚÚ¿ÎÙË.OÊı·ÏÌoÏoÁ›· 4, 4: 324-337, 1992.11. ¢ÂÚÂÎÏ‹˜ ¢, §¿Î , ·Úı¤Ó˘ ∞. ¢È·ıÏ·ÛÙÈΤ˜ ÌÂÙ·-‚oϤ˜ Û ̿ÙÈ· Ì ÂÓ‰o‚oÏ‚È΋ ÛÈÏÈÎfiÓË. OÊı·ÏÌo-ÏoÁ›· 1, 4: 350-352, 1989.12. ¢ÂÚÂÎÏ‹˜ ¢. ∏ Ù¯ÓÈ΋ Ù˘ Â͈appleÂÚÈÊ·ÎÈ΋˜ ÂÍ·›ÚÂÛ˘Ùo˘ ηٷÚÚ¿ÎÙË Î·È ¤ÓıÂÛ˘ ÂÓ‰oÊ·Îo‡ oappleÈÛı›o˘ı·Ï¿Ìo˘ Ì ÙË ¯Ú‹ÛË ‰È·ÙËÚËÙ‹ ı·Ï¿Ìo˘ . OÊı·Ï-ÌoÏoÁ›· 1, 1: 27-35, 1989.13. ¢ÂÚÂÎÏ‹˜ ¢, §¿Î , ∫o„·¯Â›Ï˘ ∂, ·apple·˚ˆ¿ÓÓo˘ £,°È¿ÎoÌapple . ∂ÌappleÂÈÚ›· ·applefi ÙËÓ ÂÊ·ÚÌoÁ‹ 500 ·ÎÚ˘ÏÈ-ÎÒÓ ÂÓ‰oÊ·ÎÒÓ. OÊı·ÏÌoÏoÁ›· 11,2 :162-168, 1999.14. ¢ÂÚÂÎÏ‹˜ ¢, §¿Î , ªappleÚ·˙ÈÙ›Îo˜ , °È¿ÎoÌapple ,∞Ó‰Úo‡‰Ë , ªÈÎÚfiappleo˘Ïo˜ ¢, Ù¿ÁÎo˜ ¡. ∂Á¯Â›ÚËÛËÙÚ·˘Ì·ÙÈÎo‡ ηٷÚÚ¿ÎÙË, ‚ÈÙÚÂÎÙoÌ‹, ·Ê·›ÚÂÛË ÂÓ-‰o‚oÏ‚ÈÎo‡ ͤÓo˘ ÛÒÌ·Ùo˜ Î·È ÂÊ·ÚÌoÁ‹ ÂÓ‰oÊ·Îo‡Û ¤Ó· ¯ÚfiÓo. OÊı·ÏÌoÏoÁ›· 12, 2: 158-165, 2000.15. Dohrmann KP, Atkins RE, Roth FD. Results in cataractextraction after retinal detachment Surgery. ModProbl Ophthalmol 18: 484-493, 1977.16. Faulborn J, Conway BP, Machemer R. Surgical Complicationsof pars plana vitreons Surgery. Ophthalmology95: 870-876, 1988.17. Freeman WR, Stanley PA, Kim JW. Vitrectomy for thetreatment of full-thickness stage 3 or 4 macular holes.Arch Ophthalmol 115: 11-21, 1997.18. Grusha YD, Masket S, Miller KM. Phacoemulcificationand lens implantation after pars plana vitrectomy.Ophthalmolory 105: 287-294, 1998.19. Haimann MH, Abrams GW. Prevention of lens opacificationduring diabetic vitrectomy. Ophthalmology 91:116-121, 1984.20. Hakin KN, Lavin MS, Leaver PK. Primary vitrectomy forrhegmatogenous retinal detachment. Graefes ArchClin Exp Ophthalmol 231: 344-346, 1993.21. Helbing H, Kellner V, Bornfeld N, Foerster MH. CataractSurgery and Yag Laser Capsulotomy Following Vitrectomyfor diabetic retinopathy. Ger J Ophthalmol 5:408-414, 1997.22. Hutton WL, Pesicka GA, Fuller DG. Cataract extractionin diabetic eye after vitrectomy. Am J Ophthalmol104: 1-4, 1987.23. Lacalle VD, Garate FJO, Alday NM. Phacoemulcificationcataract surgery in vitrectomized eyes. J CatarRefract Surg 24: 806-809, 1998.24. §¿Î , ¢ÂÚÂÎÏ‹˜ ¢, ∞ÏÂÍ·Ó‰Ú›‰Ë˜ ∞, º·ÓÙ¤Ï ∂, μo˘-ÓoÙÚ˘apple›‰Ë˜ ∏. ∂appleÈappleÏoΤ˜ ÂÓ‰o‚oÏ‚È΋˜ ÛÈÏÈÎfiÓ˘.OÊı·ÏÌoÏoÁ›· 1, 2: 109- 113, 1989.25. Leaver, Grey RHB, Garner A. Silicone oil injection in thetreatment of massive preretinal retraction.26. Lucke KH, Foerter MH, Laqua H. Long term results ofvitrectomy and silicone oil in 500 cases of complicatedretinal detachments. Am J Ophthalmol 104: 624-633,1987.25. Margherio RR, Cox MS Jr, Trese MT. Removal of epimacularmembranes. Ophthalmology 92: 1075-1083, 1985.26. Mc Cuen BW, Klombers L. The choice of posteriorchamber intraocular lens style in patiens with diabeticretinopathy. Arch Ophthalmol 108: 1376-1377, 1980.27. Mc Dermott ML, Puklin JE, Abrams GW, Eliot D. Phacoemulsificationfor cataract following pars plana vitrectomy.OphthalmicSurg Lasers 28: 558-564, 1997.28. Melberg MS, Thomas MA. Nuclear sclerotic cataractafter vitrectomy in patiens younger than 50 years ofage.Ophthalmology 102: 1466-1471, 1995.29. Mester V, Grewing R. Linsentrubungen nach pars planavitrectomie.Fortschr Ophthalmol 86: 429-432, 1989.30. Meyers SM, Klein R, Chandra S, Meyers FL. Unplannedextracapsular cataract extraction in postvitrectomyeyes.Am J Ophthalmol 86: 624-626, 1978.31. Michels RG. Vitrectomy for macular pucker. Ophthalmology91: 134-138, 1984.32. Nakazawa M, Kimizuka Y, Watabe T. Visual outcome aftervitrectomy for diabetic retinopathy: A five year followup. Acta Ophthalmol 97: 627-631, 1993.33. Novak MA, Rice TA, Michels RG, Aner C. The crystallinelens after vitrectomy for diabetic retinopathy. Ophthalmology91: 1480- 1484, 1984.34. Ogura Y, Takanashi T, Ishigooka H, Ogino N. Quantativeanalysis of lens change after vitrectomy. Am J Ophthalmology111: 179-183, 1991.35. Pesin SR, Oik RJ, Grand Hg. Vitrectomy for premacularfibroplasia: Prognostic Factors, long term follow upand time course of visual improvement. Ophthalmology98: 1109-1114, 1991.36. Poliner LS, Oik RJ, Grand MG. Surgical management ofpremacular fibroplasia. Arch Ophthalmol 106: 761-764, 1984.37. Ruellau YH, Hamard H, Fu WL. Cataracte et implantationsur oil vitrectomise. J Fr Ophthalmol 16: 315-319, 1993.38. Saunders DC, Brown A, Jones NP. Extracapsular cataractextraction after vitrectomy. J Cataract RefractSurg 22: 218-221, 1996.39. Smiddy WE, Stark WJ, Michels RG. Cataract extractionafter vitrectomy. Ophthalmology 94: 483-487, 1987.40. Sneed S, Parrish RK II, Mandelbanm S, Gray G. Technicalproblems of extracapsular cataract extraction aftervitrectomy. Arch Ophthalmol 102: 1077-10778, 1984.41. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP. Progressionnuclear sclerosis and long term visual resultsof vitrectomy with tranforming growth factor beta 2for macular holes. Am J Ophthalmol 119: 48-54, 1995.42. Wilbrandt HR, Wilbrandt TH. Phacogenesis and managementof the lens- iris diaphragm retropulsion syndromeduring phacoemulsification. J cataract RefractiveSurg 20: 48-53, 1994.
∫ÏÈÓÈΤ˜ Î·È ÂÚÁ·ÛÙËÚȷΤ˜ ÌÂϤÙ˜∂appleÈ̤ÏÂÈ·: ¡. °ÂˆÚÁÈ¿‰Ë˜e-mail: gnick@med.auth.grO ÂappleÈappleÔÏ·ÛÌfi˜ ÙÔ˘ Û˘Ó‰ÚfiÌÔ˘ ·appleÔÊÔÏ›‰ˆÛ˘ÛÙÔ NÔÌfi ¤ÏÏ·˜. TÛÈÚÒÓË 1 , A. Mapple¤ÓÔ˜2, A. Z·ÊÂÈÚÈ¿‰Ë˜1, . Mȯ·‹Ï 1 , A. TÚ˘ÊˆÓ›‰Ô˘1, °. TÛ·Ô‡Û˘1The frequency of exfoliation syndrome in the populationof the Greek Region of PellaS. Tsironi, A. Benos, A. Zafiriadis, P. Mihail, A. Trifonidou, G. TsaousisÎÔapplefi˜: O appleÚoÛ‰ÈoÚÈÛÌfi˜ Ùo˘ ˘Ó‰ÚfiÌo˘ ∞appleoÊoÏ›‰ˆ-Û˘ (∞) ÛÙoÓ appleÏËı˘ÛÌfi Ùo˘ ÓoÌo‡ ¤ÏÏ·˜. ∞ÛıÂÓ›˜Î·È ̤ıo‰o˜: ∂Ê·ÚÌfiÛÙËΠappleÚoηıoÚÈṲ̂Óo ÂÍÂÙ·ÛÙÈ-Îfi appleÚˆÙfiÎoÏÏo Î·È ÂÍÂÙ¿ÛÙËÎ·Ó 700 ¿ÙoÌ· ·applefi 45 ÂÙÒÓÎ·È ¿Óˆ (350 ¿Ó‰Ú˜ Î·È 350 Á˘Ó·›Î˜), appleo˘ appleÚoÛ‹Ïı·ÓÌÂÙ¿ ·applefi appleÚfiÛÎÏËÛË ÁÈ· appleÚoÏËappleÙÈÎfi ¤ÏÂÁ¯o. ∏ ·Ó·ÏoÁ›·ÙˆÓ ÂÍÂÙ·Ûı¤ÓÙˆÓ ˆ˜ appleÚo˜ ÙËÓ Âapple·Ú¯›· appleÚo¤ÏÂ˘Û‹˜Ùo˘˜ Î·È ÙËÓ ÎoÈÓˆÓÈ΋ Û‡ÓıÂÛË, ÙËÚ‹ıËΠÛÙo ‰Â›ÁÌ·fiappleˆ˜ ‰È·appleÈÛÙÒıËΠ·applefi Ù· ÛÙoȯ›· Ù˘ ∂ıÓÈ΋˜ Ù·ÙÈ-ÛÙÈ΋˜ ÀappleËÚÂÛ›·˜. ∞appleoÙÂϤÛÌ·Ù·: ∞ ‰È·appleÈÛÙÒıËΠÛÂappleoÛoÛÙfi 10% ÛÙo Û‡ÓoÏo Ùo˘ ‰Â›ÁÌ·Ùo˜. Δ· appleoÛoÛÙ¿ ∞appleo˘ ‰È·appleÈÛÙÒıËÎ·Ó ·Ó¿ ËÏÈÎȷ΋ oÌ¿‰· ‹Ù·Ó 0% ÛÙËÓoÌ¿‰· ·applefi 45-54 ÂÙÒÓ, 2% ÛÙËÓ oÌ¿‰· 55-64, 21,33%ÛÙËÓ oÌ¿‰· 65-74 Î·È 34% ÛÙËÓ oÌ¿‰· Ì ËÏÈΛ· ·applefi 75ÂÙÒÓ Î·È ¿Óˆ. ¢ÂÓ ‰È·appleÈÛÙÒıËΠÛÙ·ÙÈÛÙÈÎÒ˜ ÛËÌ·ÓÙÈ΋‰È·ÊoÚ¿ ÂappleÈappleoÏ·ÛÌo‡ Ùo˘ ∞ ·Ó¿ÌÂÛ· ÛÙȘ ÙÚÂȘ Âapple·Ú-¯›Â˜ Ùo˘ ÓoÌo‡ ¤ÏÏ·˜. Ù· ‰‡o ʇϷ ∞ ÂÌÊ·Ó›ÛÙËΠÛÂappleoÛoÛÙ¿ 8,85% (¿Ó‰Ú˜) Î·È 11,14% (Á˘Ó·›Î˜), ¯ˆÚ›˜ÛÙ·ÙÈÛÙÈο ÛËÌ·ÓÙÈ΋ ‰È·ÊoÚ¿.  appleoÛoÛÙfi 12,7% ÙˆÓ·ÙfiÌˆÓ ÂÓÙoapple›ÛÙËÎ·Ó ‡appleoappleÙ· Â˘Ú‹Ì·Ù· ÁÈ· ·Ó¿appleÙ˘ÍË ∞ÛÙo ̤ÏÏoÓ. ∏ ̤ÛË ∂O ÙˆÓ ·ÙfiÌˆÓ Ì ∞ ‹Ù·Ó 20,04mmHg, ÛÙ·ÙÈÛÙÈο ÛËÌ·ÓÙÈο ˘„ËÏfiÙÂÚË ·applefi ÙˆÓ ˘appleo-Ïo›appleˆÓ, appleo˘ ‹Ù·Ó 15,37 mmHg.  12 ·applefi Ù· 70 ¿ÙoÌ·Ì ∞ (appleoÛoÛÙfi 17,14%) ˘apple‹Ú¯Â ÂÁηÙÂÛÙË̤Óo, ÌË ‰È·-ÁÓˆṲ̂Óo ·appleoÊoÏȉˆÙÈÎfi ÁÏ·‡ÎˆÌ· (∞°), ÂÓÒ ‰È·appleÈÛÙÒıËηÓ9 ¿ÙoÌ· Ì ÌË ‰È·ÁÓˆṲ̂Óo ¯ÚfiÓÈo ÁÏ·‡ÎˆÌ··Óoȯً˜ ÁˆÓ›·˜ (ð∞°) (appleoÛoÛÙfi 1,43%) ÛÙ· ¿ÙoÌ· ¯ˆ-Ú›˜ ∞. ˘ÌappleÂÚ¿ÛÌ·Ù·: O ÂappleÈappleoÏ·ÛÌfi˜ Ùo˘ ∞ Û¿ÙoÌ· ËÏÈΛ·˜ 45 ÂÙÒÓ Î·È ¿Óˆ Ùo˘ ÓoÌo‡ ¤ÏÏ·˜ ·Ó¤Ú-¯ÂÙ·È Û 10% Û‡Ìʈӷ Ì ٷ Â˘Ú‹Ì·Ù· Ù˘ ÌÂϤÙ˘. ΔoappleoÛoÛÙfi ·˘Í¿ÓÂÙ·È ‰Ú·Ì·ÙÈο Û ۯ¤ÛË Ì ÙËÓ ¿Óo‰oÙ˘ ËÏÈΛ·˜. Δ· Â˘Ú‹Ì·Ù· appleo˘ ¤¯o˘Ó Û¯¤ÛË Ì Ùo ÁÏ·‡-Έ̷ Î·È ÙËÓ ∂O Û˘ÌʈÓo‡Ó Ì ÙËÓ ‚È‚ÏÈoÁÚ·Ê›·.Purpose: To determine the prevalence of exfoliationsyndrome in the population of Pella. Material andmethods: We studied 700 individuals (350 women and350 men), older than 45. A specified protocol was usedto record the exfoliation findings as well as the suspectclinical signs of exfoliation. Certain information from theNational Statistical Service was used in order to employa cluster, stratified sampling, representative of thepopulation of the region of Pella. Results: Evidentclinical findings were detected in the 10% of theexamined persons. The percentage of evident exfoliationsyndrome was 0% for the group of age 45-54, 2% for thegroup 55-64, 21,33% for the group 66-74 and 34% forthe group of individuals who were older than 75. Therewas no statistically significant difference between thetwo sexes concerning the prevalence of exfoliationsyndrome. Average IOP was higher (20,04 mmHg) forthe patients with exfoliation syndrome than the rest ofthe examined persons (15,37 mmHg). 12 persons fromthe ones with exfoliation syndrome had undiagnosedexfoliative glaucoma, while 9 from the persons withoutexfoliation syndrome had undiagnosed open-angleglaucoma. Conclusions: The prevalence of exfoliationsyndrome in the area of Pella was determined to 10% forpeople older than 45. The percentage of the prevalencearises dramatically for the elder. The findings of thepresent study concerning glaucoma and IOP are similarto those referred by the literature.1OÊı·ÏÌoÏoÁÈ΋ KÏÈÓÈ΋ °ÂÓÈÎÔ‡ ¡Ô̷گȷÎÔ‡ ¡ÔÛÔÎÔÌ›Ԣ Œ‰ÂÛÛ·˜2∂ÚÁ·ÛÙ‹ÚÈÔ ÀÁÈÂÈÓ‹˜, ΔÌ‹Ì· π·ÙÚÈ΋˜, ∞ÚÈÛÙÔÙ¤ÏÂÈÔ ·ÓÂappleÈÛÙ‹ÌÈÔ £ÂÛÛ·ÏÔӛ΢OÊı·ÏÌÔÏÔÁ›·, 14, 2 : 161 - 170, 2002 161
- Page 5 and 6: ¯fiÏÈÔO Û‚·ÛÙfi˜ K·ı
- Page 7 and 8: OphthalmologiaContentsVolume 14 - N
- Page 9 and 10: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 11 and 12: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 13 and 14: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 15 and 16: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 17 and 18: AÓ·ÛÎfiappleËÛË∂appleÈÌ
- Page 19 and 20: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 21: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 25 and 26: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 27 and 28: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 29 and 30: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 31 and 32: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 33 and 34: ‡ÁÎÚÈÛË Ù˘ 24ˆÚ˘
- Page 35 and 36: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 37 and 38: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 39 and 40: ∏ ¯Ú‹ÛË Ù˘ ·ÏÏ·ÓÙ
- Page 41 and 42: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 43 and 44: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 45 and 46: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 47 and 48: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 49 and 50: OÊı·ÏÌÈο ÙÚ·‡Ì·Ù·
- Page 51 and 52: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 53 and 54: OappleÙÈ΋ o͇ÙËÙ·, ‰
- Page 55 and 56: OÊı·ÏÌÔÏÔÁ›·, 14, 2 (20
- Page 57 and 58: ∂ӉȷʤÚÔÓÙ· appleÂ
- Page 60 and 61: 198 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 62 and 63: 200 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 64 and 65: 202 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 66 and 67: 204 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 68 and 69: ‡ÌÌÂÈÎÙ·∂appleÈ̤ÏÂ
- Page 70 and 71: 208 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 72 and 73:
O ÔÊı·ÏÌfi˜ οÙÔappleÙ
- Page 74 and 75:
212 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 76 and 77:
214 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 78 and 79:
·ıÔÁ¤ÓÂÈ· Ù˘ ˘appleÂ
- Page 80 and 81:
218 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 82 and 83:
220 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 84 and 85:
222 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 86 and 87:
224 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 88 and 89:
226 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 90 and 91:
228 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 92 and 93:
230 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 94 and 95:
232 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 96 and 97:
234 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 98 and 99:
236 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 100 and 101:
238 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 102 and 103:
240 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 104 and 105:
242 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 106 and 107:
244 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 108 and 109:
246 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 110 and 111:
248 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 112 and 113:
ÂÚÈÏ‹„ÂȘ ·applefi ͤ
- Page 114 and 115:
252 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 116 and 117:
254 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 118 and 119:
256 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 120 and 121:
BÈ‚ÏÈÔÎÚÈÛ›·¡ÈÎfiÏ
- Page 122 and 123:
260 OÊı·ÏÌÔÏÔÁ›·, 14, 2
- Page 124:
Eȉ‹ÛÂȘ∂appleÈ̤ÏÂ